Match!
Juan Castaño
Autonomous University of Barcelona
23Publications
3H-index
32Citations
Publications 23
Newest
#1Guillem PailhezH-Index: 11
#2Juan CastañoH-Index: 3
Last.Antonio BulbenaH-Index: 22
view all 7 authors...
Resumen Objetivo Desarrollar y validar la escala Trastorno Psiquiatrico y Patologia Somatica (TOPYPS), un instrumento disenado para: a) detectar, con un alto grado de sospecha, las patologias funcionales mas frecuentes segun los criterios diagnosticos estandarizados, y b) evaluar de forma rapida, global y fiable el estado de salud fisica en poblacion general. Diseno Validacion de una escala. Emplazamiento Centro de atencion primaria, Barcelona. Participantes La escala se administro a 67 adultos ...
Source
#1Antonio BulbenaH-Index: 2
#2Rafael MaldonadoH-Index: 71
view all 11 authors...
#1Guillem PailhezH-Index: 11
#2Juan CastañoH-Index: 3
Last.Antonio BulbenaH-Index: 2
view all 8 authors...
Source
INTRODUCTION: To analyze factors associated with clinical observation, pharmacotherapy and referral on discharge of patients with anxiety disorder (AD) seeking care at a psychiatric emergency unit. METHOD: A total of 5003 consecutive visits were reviewed over a three-year period at a psychiatric emergency service in a tertiary university hospital. Data collected included sociodemographic and clinical information as well as the Global Assessment of Functioning (GAF) and the Severity Psychiatric I...
#1Victoria Martín-Escudero (Hoffmann-La Roche)H-Index: 1
#2Montserrat Garcia-Retortillo (Autonomous University of Barcelona)H-Index: 12
Last.Ricard Solà (Autonomous University of Barcelona)H-Index: 37
view all 17 authors...
Source
Source
#1C. GarnierH-Index: 1
#2Juan CastañoH-Index: 3
Last.Antoni BulbenaH-Index: 19
view all 9 authors...
Results Antipsychotics are used in 27% of the patients, with a predominancy in the female gender (77.8%), a global average age of 57.9 ± 12.6 years. There is a predominancy of absence of psychiatric background (55.6%) and the absence of previous hospitalisations (66.7%). In 96.3% of the sample there was no toxic abuse. It is observed the following distribution in the use of antipsychotics: quetiapine and olanzapine (29.6% each one), risperidone (26%), paliperidone (3%). Average dose was 5.7 mg/d...
Source
#1C. GarnierH-Index: 1
#2B. DiazH-Index: 1
Last.Antoni BulbenaH-Index: 19
view all 9 authors...
Results There is use of BZD in a 76% of the sample, with a predominancy of the female gender (72.4% vs 27.6%), a global average age of 56.55 ± 12.4 years. In relation to personal psychiatric background it can be observed in 47.4% the absence of these, followed by 39.5% in which there is presence of previous depressive episodes. There is a predominancy in the absence of toxic abuse (97.4%) and the absence of previous hospitalisations (81%) It can be observed the following distribution by frequenc...
Source
#1C. GarnierH-Index: 1
#2Juan CastañoH-Index: 3
Last.Antoni BulbenaH-Index: 19
view all 9 authors...
BackgroundMajor depressive disorder (MDD) is a common and dis-abling psychiatric condition. Antidepressants are cur-rently the mainstay of treatment for depression;however, almost two thirds of patients will fail toachieve remission with initial treatment, as a result, arange of augmentation and combination strategies havebeen used [1].Materials and methodsMajor depressive disorder (MDD) is a common and dis-abling psychiatric condition. Antidepressants are cur-rently the mainstay of treatment fo...
Source
Background According to the American Psychiatric Association practice guidelines, if a patient with Major Depressive Disorder (MDD) has not responded or achieved only a partial response after 4-8 weeks of therapy, a dose change, switch to a new drug, or augmentation therapy is recommended [1]. Combined use of standard antidepressants with dopaminergic agents and psychostimulants can lead to accelerate and enhance response if administered early in the course of treatment [2].
Source
123